Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)

Alzheimer's Disease Clinical Trial

— CREDOS  

Official title:

Clinical Research Center for Dementia of South Korea (CREDOS)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01198093
• Other study ID #: 2005-02-008
• Status: Recruiting
• Phase: N/A
• First received: September 8, 2010
• Last updated: September 26, 2012
• Start date: November 2005
• Est. completion date: August 2015

Study information

• Verified date: September 2012
• Source: Samsung Medical Center
• Contact: Doh K Kim, Ph.D
• Phone: 82-2-3410-3582
• Email: dohkwan.kim[@]samsung.com
• Is FDA regulated: No
• Health authority: South Korea: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The objective of this study is to present evidence-based medicine for development of clinical practice guideline through prospective study of Alzheimer's disease(AD) and mild cognitive impairment(MCI) in korea

Description:

The specific aims of this study is (1) construction & maintenance of cohort for Alzheimer's disease(AD) and mild cognitive impairment(MCI); (2) study of epidemiology, rate of progression, risk factor, prognostic factor; (3) study of biomarker such as neuropsychological assessment, peripheral & CSF markers, neuroimaging(both structural & functional)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 800
• Est. completion date: August 2015
• Est. primary completion date: August 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Alzheimer's disease(AD) and mild cognitive impairment(MCI)will be enrolled in the study.

1. the diagnostic criteria of Alzheimer's disease(AD) according to DSM IV or NINCDS -ADRDA

2. the diagnostic criteria of mild cognitive impairment(MCI) A. Memory or other cognitive complaint preferably corroborated by an informant B. Objective memory impairment or other cognitive for age and education C. Largely intact general cognitive function D. Essentially preserved ADL E. Not demented

Exclusion Criteria:

• Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease

Locations

Country	Name	City	State
Korea, Republic of	Samsung Medical Center	Seoul	Kangnam-Ku

Sponsors (2)

Lead Sponsor	Collaborator
Samsung Medical Center	Ministry of Health & Welfare, Korea

Country where clinical trial is conducted

Korea, Republic of,